Wellington Management Group LLP Cuts Position in Calumet, Inc. $CLMT

Key Points

• Wellington Management reduced its Calumet position by 2.3%, selling 19,076 shares and retaining 811,482 shares worth approximately $29.2 million. Institutional investors collectively own 34.41% of the company.
• Analyst sentiment remains mixed, with two Buy ratings, four Holds and one Sell; the consensus rating is Hold with a $51.75 price target. HC Wainwright raised its target to $75, while UBS and TD Cowen maintained neutral ratings.
• Calumet reported a quarterly loss of $1.09 per share, missing the $0.07 consensus estimate, although revenue rose 40.8% year over year to $1.45 billion. Shares opened at $53.13, near the company’s 52-week high of $54.69.

Wellington Management Group LLP decreased its position in Calumet, Inc. (NASDAQ:CLMT - Free Report) by 2.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 811,482 shares of the oil and gas company's stock after selling 19,076 shares during the quarter. Wellington Management Group LLP owned 0.92% of Calumet worth $29,230,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of CLMT. Islay Capital Management LLC purchased a new position in shares of Calumet in the fourth quarter valued at $25,000. Aster Capital Management DIFC Ltd lifted its position in Calumet by 294.7% during the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company's stock valued at $33,000 after purchasing an additional 1,229 shares during the last quarter. Global Retirement Partners LLC purchased a new position in shares of Calumet in the 4th quarter worth $34,000. Covestor Ltd increased its holdings in shares of Calumet by 29.1% in the 4th quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company's stock worth $43,000 after buying an additional 492 shares during the last quarter. Finally, Advisory Services Network LLC purchased a new stake in shares of Calumet during the 3rd quarter valued at about $59,000. 34.41% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

CLMT has been the subject of a number of analyst reports. TD Cowen increased their price target on shares of Calumet from $34.00 to $40.00 and gave the company a "hold" rating in a report on Wednesday, August 12th. UBS Group upped their price objective on Calumet from $26.00 to $47.00 and gave the company a "neutral" rating in a research report on Tuesday, August 25th. HC Wainwright lifted their target price on Calumet from $60.00 to $75.00 and gave the stock a "buy" rating in a report on Wednesday. Weiss Ratings reissued a "sell (d-)" rating on shares of Calumet in a research report on Friday, August 7th. Finally, Citigroup restated a "buy" rating on shares of Calumet in a research report on Monday, August 10th. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $51.75.

Insider Buying and Selling

In other Calumet news, Director Daniel Sajkowski sold 4,240 shares of the stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $36.16, for a total value of $153,318.40. Following the sale, the director owned 77,718 shares in the company, valued at $2,810,282.88. This trade represents a 5.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 3.15% of the stock is owned by company insiders.

More Calumet News

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright raised its earnings forecasts and maintained a Buy rating. The firm increased its Q3 2026 EPS estimate to $0.62 from $0.60, Q4 to $0.24 from $0.22, FY2026 to $0.17 from $0.12, and FY2027 to $1.11 from $0.59. Its $75 price target implies substantial upside from the stock’s recent trading level. HC Wainwright earnings estimate report
• Positive Sentiment: The upward revisions suggest HC Wainwright expects stronger profitability over the next several quarters, potentially reflecting improved operating performance or business conditions. The revised FY2027 forecast is notably above the broader current-year consensus estimate of $0.46 per share. Calumet stock price expected to rise
• Neutral Sentiment: Calumet announced plans to attend the H.C. Wainwright conference. The event could provide investors with updates on strategy and operations, but no new financial information was disclosed in the announcement. Calumet conference announcement
• Neutral Sentiment: A Zacks analysis compared Calumet’s year-to-date performance with TXO Partners and the broader oil-and-energy sector. The article provides relative-performance context but does not indicate a new company-specific catalyst. Zacks Calumet sector performance analysis
• Negative Sentiment: Pomerantz LLP announced an investigation into potential claims on behalf of Calumet investors. Although the announcement does not establish wrongdoing, the prospect of litigation or regulatory concerns may weigh on sentiment and introduce uncertainty. Pomerantz investor investigation

Calumet Price Performance

Shares of NASDAQ CLMT opened at $53.13 on Friday. Calumet, Inc. has a 1 year low of $16.75 and a 1 year high of $54.69. The firm has a 50-day simple moving average of $43.76 and a two-hundred day simple moving average of $36.21. The company has a market cap of $4.67 billion, a P/E ratio of -34.28 and a beta of 0.72.

Calumet (NASDAQ:CLMT - Get Free Report) last released its earnings results on Friday, August 7th. The oil and gas company reported ($1.09) EPS for the quarter, missing analysts' consensus estimates of $0.07 by ($1.16). The firm had revenue of $1.45 billion during the quarter, compared to analysts' expectations of $1.12 billion. During the same quarter last year, the company posted ($1.70) earnings per share. The business's revenue was up 40.8% on a year-over-year basis. As a group, equities research analysts expect that Calumet, Inc. will post 0.48 EPS for the current year.

Calumet Profile

Calumet Specialty Products Partners, L.P. NASDAQ: CLMT is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet's product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source